rs17379472

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 2P and 20B. PM1BP4_StrongBP6_Very_StrongBS1BS2

The NM_201525.4(ADGRG1):​c.1460T>C​(p.Met487Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0341 in 1,614,038 control chromosomes in the GnomAD database, including 1,132 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M487I) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.028 ( 88 hom., cov: 32)
Exomes 𝑓: 0.035 ( 1044 hom. )

Consequence

ADGRG1
NM_201525.4 missense

Scores

5
6
6

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 5.95

Publications

14 publications found
Variant links:
Genes affected
ADGRG1 (HGNC:4512): (adhesion G protein-coupled receptor G1) This gene encodes a member of the G protein-coupled receptor family and regulates brain cortical patterning. The encoded protein binds specifically to transglutaminase 2, a component of tissue and tumor stroma implicated as an inhibitor of tumor progression. Mutations in this gene are associated with a brain malformation known as bilateral frontoparietal polymicrogyria. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
ADGRG1 Gene-Disease associations (from GenCC):
  • bilateral frontoparietal polymicrogyria
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_201525.4
BP4
Computational evidence support a benign effect (MetaRNN=0.008508056).
BP6
Variant 16-57659586-T-C is Benign according to our data. Variant chr16-57659586-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 137495.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0282 (4288/152268) while in subpopulation NFE AF = 0.0375 (2550/68022). AF 95% confidence interval is 0.0363. There are 88 homozygotes in GnomAd4. There are 2186 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 88 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ADGRG1NM_201525.4 linkc.1460T>C p.Met487Thr missense_variant Exon 11 of 14 ENST00000562631.7 NP_958933.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ADGRG1ENST00000562631.7 linkc.1460T>C p.Met487Thr missense_variant Exon 11 of 14 1 NM_201525.4 ENSP00000455351.2

Frequencies

GnomAD3 genomes
AF:
0.0282
AC:
4286
AN:
152150
Hom.:
88
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00637
Gnomad AMI
AF:
0.0570
Gnomad AMR
AF:
0.0295
Gnomad ASJ
AF:
0.0164
Gnomad EAS
AF:
0.00116
Gnomad SAS
AF:
0.0174
Gnomad FIN
AF:
0.0727
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0375
Gnomad OTH
AF:
0.0229
GnomAD2 exomes
AF:
0.0328
AC:
8240
AN:
251372
AF XY:
0.0323
show subpopulations
Gnomad AFR exome
AF:
0.00554
Gnomad AMR exome
AF:
0.0335
Gnomad ASJ exome
AF:
0.0142
Gnomad EAS exome
AF:
0.000598
Gnomad FIN exome
AF:
0.0736
Gnomad NFE exome
AF:
0.0400
Gnomad OTH exome
AF:
0.0350
GnomAD4 exome
AF:
0.0347
AC:
50760
AN:
1461770
Hom.:
1044
Cov.:
35
AF XY:
0.0341
AC XY:
24800
AN XY:
727194
show subpopulations
African (AFR)
AF:
0.00511
AC:
171
AN:
33480
American (AMR)
AF:
0.0342
AC:
1528
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0153
AC:
401
AN:
26136
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39700
South Asian (SAS)
AF:
0.0165
AC:
1421
AN:
86258
European-Finnish (FIN)
AF:
0.0686
AC:
3661
AN:
53390
Middle Eastern (MID)
AF:
0.00954
AC:
55
AN:
5768
European-Non Finnish (NFE)
AF:
0.0375
AC:
41742
AN:
1111928
Other (OTH)
AF:
0.0293
AC:
1772
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
2929
5858
8786
11715
14644
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1528
3056
4584
6112
7640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0282
AC:
4288
AN:
152268
Hom.:
88
Cov.:
32
AF XY:
0.0294
AC XY:
2186
AN XY:
74444
show subpopulations
African (AFR)
AF:
0.00636
AC:
264
AN:
41540
American (AMR)
AF:
0.0296
AC:
453
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.0164
AC:
57
AN:
3470
East Asian (EAS)
AF:
0.00135
AC:
7
AN:
5174
South Asian (SAS)
AF:
0.0174
AC:
84
AN:
4826
European-Finnish (FIN)
AF:
0.0727
AC:
772
AN:
10618
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0375
AC:
2550
AN:
68022
Other (OTH)
AF:
0.0227
AC:
48
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
215
429
644
858
1073
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
50
100
150
200
250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0339
Hom.:
312
Bravo
AF:
0.0242
TwinsUK
AF:
0.0359
AC:
133
ALSPAC
AF:
0.0387
AC:
149
ESP6500AA
AF:
0.00614
AC:
27
ESP6500EA
AF:
0.0348
AC:
299
ExAC
AF:
0.0319
AC:
3878
Asia WGS
AF:
0.0150
AC:
52
AN:
3478
EpiCase
AF:
0.0339
EpiControl
AF:
0.0363

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jan 30, 2024
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 20, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 07, 2013
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 27, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bilateral frontoparietal polymicrogyria Benign:2
Nov 26, 2019
Natera, Inc.
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.68
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Uncertain
0.070
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.42
.;T;T;.;.;.;.;.
Eigen
Pathogenic
0.73
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.78
.;.;T;.;T;.;.;T
MetaRNN
Benign
0.0085
T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.63
T
PhyloP100
6.0
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-5.9
D;D;D;D;.;D;D;D
REVEL
Uncertain
0.53
Sift
Benign
0.044
D;D;D;D;.;D;D;D
Sift4G
Pathogenic
0.0
D;D;D;D;D;D;D;D
Polyphen
0.93
P;D;D;P;.;P;P;P
Vest4
0.48
ClinPred
0.018
T
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.57
gMVP
0.82
Mutation Taster
=28/72
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17379472; hg19: chr16-57693498; API